SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001703057-23-000008
Filing Date
2023-05-04
Accepted
2023-05-04 16:57:45
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-20230331.htm   iXBRL 10-Q 1377677
2 EX-31.1 abcl-20230331xexx311.htm EX-31.1 10508
3 EX-31.2 abcl-20230331xexx312.htm EX-31.2 10471
4 EX-32.1 abcl-20230331xexx321.htm EX-32.1 4868
5 EX-32.2 abcl-20230331xexx322.htm EX-32.2 4845
11 abcl-20230331_g1.gif GRAPHIC 328285
  Complete submission text file 0001703057-23-000008.txt   6007449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20230331.xsd EX-101.SCH 34272
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abcl-20230331_cal.xml EX-101.CAL 64628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20230331_def.xml EX-101.DEF 133062
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20230331_lab.xml EX-101.LAB 432941
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20230331_pre.xml EX-101.PRE 263210
57 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20230331_htm.xml XML 662813
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 23889747
SIC: 2834 Pharmaceutical Preparations